Rep. Levin and Rep. Valadao Introduce Bipartisan Bill to Coordinate Global Fight Against Superbugs
The SUPER BUGS Act of 2026 is currently sitting in the House Committee on Foreign Affairs. Nothing has happened with this bill since it was introduced in March 2026, which means it has been stalled for four months. The committee must take action before the bill can move forward.
The bill has support from both parties, which helps it move forward. However, many bills about international strategy are introduced but never make it through the full voting process.
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 1305 (118th), which died when its Congress ended.
H.R. 1305 (118th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
The bill encourages the government to partner with U.S. companies, including through contracts and public-private partnerships, to develop pandemic and epidemic products. Small biotech and pharmaceutical firms could benefit from new funding streams and streamlined regulatory pathways, though the bill creates no specific programs yet -- it only requires a strategy.
“consider securing contracts with United States companies and the broader private sector, entering into public-private partnerships, implementing alternative payment models”
Referred to the House Committee on Foreign Affairs.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
SUPER BUGS Act of 2026
Analysis generated by AI. Always verify with official sources.
